In an effort to understand early molecular events associated AD we investigated the STG, a region that is moderately affected in the AD brain with characteristic Aβ pathology, including neuritic plaques, but only mild tau-related changes and minor neuronal loss. The gene discussed is MAPT; the disease is Alzheimer disease.